Related Experiment Video

Updated: Jul 14, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Clinical manifestations of tuberculosis in children

Andrea T Cruz1, Jeffrey R Starke

  • 1Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA. atcruz@texaschildrenshospital.org

Paediatric Respiratory Reviews
|June 19, 2007
PubMed

Insights

Pediatric tuberculosis (TB) presents differently than adult TB, with age and immune status influencing disease risk and presentation. Diagnosis often relies on skin tests, history, and clinical/radiographic findings due to low diagnostic test yield in children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Background:

  • Pediatric tuberculosis (TB) exhibits distinct natural history and clinical features compared to adults.
  • Age and immune status are critical determinants of TB progression risk in children.
  • Manifestations can range from miliary and meningeal TB in infants to progressive primary or cavitary disease in adolescents.

Purpose of the Study:

  • To delineate the unique epidemiological and clinical characteristics of tuberculosis in pediatric populations.
  • To highlight the influence of age and immune status on TB disease progression and presentation in children.
  • To discuss the challenges in diagnosing pediatric TB, including the lower yield of diagnostic tests.

Main Methods:

  • Review of the natural history and clinical manifestations of tuberculosis in children.
  • Analysis of factors influencing disease progression, including age and immune status.
  • Examination of common TB sites and presentation patterns in different pediatric age groups.

Main Results:

  • Neonates face the highest risk of TB progression; infants often present with miliary and meningeal involvement.
  • Children aged 5-10 years show a lower likelihood of disease development.
  • Immunocompromised children have increased risk for disease progression and extrapulmonary TB, with lower diagnostic test yields.

Conclusions:

  • Pediatric TB requires a nuanced understanding due to age- and immunity-related variations in presentation and progression.
  • Intrathoracic disease and lymphadenopathy are common, often driven by inflammatory responses.
  • Diagnosis frequently integrates skin tests, epidemiological data, and clinical/radiographic evidence, given the limited utility of other tests.

Related Concept Videos

Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...